URSOLIC ACID MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

The global ursolic acid market is estimated to be valued at USD 342.8 Mn in 2026 and is expected to reach USD 508.7 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2026 to 2033. Ursolic acid is a naturally synthesized pentacyclic triterpenoid compound extracted from many fruits, herbs, and medicinal plants like apple peels, rosemary, holy basil, cranberries, prunes and basil. This plant-based molecule has a variety of biological activities such as antioxidant, anti-inflammatory, anticancer, antimicrobial, antidiabetic and hepatoprotective properties, and therefore it finds widespread use in the development of cosmetics, pharmaceutical compounds and nutraceuticals.

 The global ursolic acid market is expanding steadily, driven by the consumer preference for natural and plant-based products, thus increasing inclination for functional food and supplements and intensive scientific research regarding the therapeutic potential of ursolic acid in the pharmaceutical segment.

Market Dynamics

The global ursolic acid market is driven by rise in the demand for plant based bioactive constituents for the pharmaceutical and cosmetics industries. Moreover, increasing demand for natural compounds by consumers, coupled with the increasing cases of lifestyle diseases including obesity, diabetes, cardiovascular diseases, and cancer are boosting the adoption of ursolic acid in pharmaceuticals, dietary supplement and active skincare products.

However, a number of constraints are present in the market, such as cost-intensive nature of isolation, low water solubility and absorption capacity of the compounds. Nevertheless, innovative developments in the area of nanotechnology related to drug delivery mechanisms, together with eco-friendly methods of isolation of the ursolic acid compound will offer new opportunities for growth in the ursolic acid market.

Key Features of the Study

• This report provides in-depth analysis of the global ursolic acid market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global ursolic acid market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Sabinsa Corporation, Changsha Staherb Natural Ingredients Co., Ltd., Geneham Pharmaceutical Co., Ltd., Acetar Bio-Tech Inc., Shaanxi Huike Botanical Development Co., Ltd., Shaanxi Jintai Biological Engineering Co., Ltd., Xuancheng Baicao Pharmaceutical Co., Ltd., Changsha E.K HERB Co., Ltd., Yongzhou Huamao Biotechnology Co., Ltd., and Sami Labs Limited
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global ursolic acid market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global ursolic acid market

Market Segmentation

• Source Insights (Revenue, USD Mn, 2021 - 2033)
  • Plant-derived
  • Synthetic/Biotechnological
• Application Insights (Revenue, USD Mn, 2021 - 2033)
  • Cosmetics and Personal Care
  • Nutraceuticals and Dietary Supplements
  • Pharmaceuticals
  • Food and Beverages
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Sabinsa Corporation
  • Changsha Staherb Natural Ingredients Co., Ltd.
  • Geneham Pharmaceutical Co., Ltd.
  • Acetar Bio-Tech Inc.
  • Shaanxi Huike Botanical Development Co., Ltd.
  • Shaanxi Jintai Biological Engineering Co., Ltd.
  • Xuancheng Baicao Pharmaceutical Co., Ltd.
  • Changsha E.K HERB Co., Ltd.
  • Yongzhou Huamao Biotechnology Co., Ltd.
  • Sami Labs Limited